CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Otsuka Pharmaceutical Co. Ltd. v. Apotex Inc.

1:15-cv-00109

Overview

Case Number 1:15-cv-00109
Filing Date 2015-01-29
Status Terminated
Termination Date 2015-12-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Apotex Corp. Operating Company

Represented By

3 Attorneys Listed

Andrew M. Alul

Email: aalul@taftlaw.com

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Apotex Inc. Operating Company

Represented By

2 Attorneys Listed

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Plaintiff

Otsuka Pharmaceutical Co. Ltd. Operating Company

Represented By

6 Attorneys Listed

Susan Krumplitsch

Email: susan.krumplitsch@us.dlapiper.com

Scott A. Sukenick

UNDELIVERABLE EMAIL 12/5/2017

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jonathan G. Graves

Email: jgraves@cooley.com

Adam M. Pivovar

Email: apivovar@cooley.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5753677
Benzoheterocyclic compounds
Filed: 1995-06-07
Issued: 1998-05-19
Expired (Term Ended) +1808d PTA
Expires: 2020-05-19
US8501730
Process for preparing benzazepine compounds or salts thereof
Filed: 2012-05-17
Issued: 2013-08-06
Active (5.5 yrs remaining)
Expires: 2032-05-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1808 days) / Cellect Scrutiny β€” Over 1808 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/22/2015. Amended Pleadings due by 5/22/201...
Entry #8 • 2015-03-03 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1665045.) - filed by Otsuka Pharmaceutical Co. Ltd.. (Attachments: # 1 Exhibit A part 1, # 2 Exhibit A part 2, # 3 Exhibit A part 3 and exh B, # 4 Civil Cover Sheet)(els) (Entered: 01/29/2015)

Entry #1 • 2015-01-29
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 01/29/2015)

Entry #2 • 2015-01-29
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/18/14. Date of Expiration of Patent: 5/19/20 and 9/1/26.Thirty Month Stay Deadline: 6/18/2017. (els) (Entered: 01/29/2015)

Entry #3 • 2015-01-29
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,753,677; 8,501,730 B2;. (els) (Entered: 01/29/2015)

Entry #4 • 2015-01-29
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co. Ltd. for Otsuka Pharmaceutical Co. Ltd. filed by Otsuka Pharmaceutical Co. Ltd.. (els) (Entered: 01/29/2015)

Entry #5 • 2015-01-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc